未登录
分享
收藏
分享
收藏Hyperactivation of mTORC1 drives acquired resistance to the pan -HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers
Sudhan, Dhivya R.; Guerrero-Zotano, Angel; Won, Helen; Ericsson, Paula Gonzales; Liu, Qi; Dugger, Teresa; Koch, James; Schram, Alison; Servetto, Alberto; Cutler, Richard; Lalani, Alshad; Bryce, Richard; Auerbach, Alan; Hanker, Ariella; Arteaga, Carlos L.
分享
收藏
分享
收藏
分享
收藏
分享
收藏